iRhythm (IRTC) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

IRTC Stock Forecast

iRhythm stock forecast is as follows: an average price target of $111.38 (represents a 23.22% upside from IRTC’s last price of $90.39) and a rating consensus of 'Buy', based on 19 wall street analysts offering a 1-year stock forecast.

IRTC Price Target

The average price target for iRhythm (IRTC) is $111.38 based on 1-year price targets from 19 Wall Street analysts in the past 3 months, with a price target range of $145.00 to $78.00. This represents a potential 23.22% upside from IRTC's last price of $90.39.

IRTC Analyst Ratings

Buy

According to 19 Wall Street analysts, iRhythm's rating consensus is 'Buy'. The analyst rating breakdown for IRTC stock is 1 'Strong Buy' (5.26%), 15 'Buy' (78.95%), 3 'Hold' (15.79%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

iRhythm Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 31, 2024	Michael Matson	Needham	$96.00	$75.77	26.70%	6.21%
Oct 22, 2024	David Rescott	Truist Financial	$95.00	$62.10	52.98%	5.10%
Oct 15, 2024	David Rescott	Robert W. Baird	$100.00	$57.94	72.61%	10.63%
Oct 14, 2024	Richard Newitter	Truist Financial	$80.00	$57.58	38.94%	-11.49%
Oct 04, 2024	David Roman	Goldman Sachs	$78.00	$66.28	17.68%	-13.71%
Sep 25, 2024	William Plovanic	Canaccord Genuity	$137.00	$70.30	94.88%	51.57%
Aug 02, 2024	Richard Newitter	Truist Financial	$117.00	$75.44	55.09%	29.44%
Aug 02, 2024	Suraj Kalia	Oppenheimer	$145.00	$84.22	72.17%	60.42%
Aug 02, 2024	Marie Thibault	BTIG	$125.00	$84.22	48.42%	38.29%
Jul 16, 2024	Richard Newitter	Truist Financial	$134.00	$102.76	30.40%	48.25%
Jun 20, 2024	Mike Polark	Wolfe Research	$115.00	$98.16	17.16%	27.23%
May 29, 2024	Marie Thibault	BTIG	$132.00	$87.77	50.39%	46.03%
May 20, 2024	Nathan Treybeck	Wells Fargo	$135.00	$94.83	42.36%	49.35%
Aug 07, 2023	Richard Newitter	Truist Financial	$138.00	$111.31	23.98%	52.67%
Feb 07, 2023		Wells Fargo	$150.00	$106.86	40.36%	65.95%
Jan 06, 2023		Morgan Stanley	$128.00	$88.20	45.12%	41.61%
Dec 20, 2022		Truist Financial	$153.00	$93.21	64.15%	69.27%
Dec 12, 2022		Citigroup	$110.00	$102.52	7.30%	21.69%
Sep 22, 2022		Morgan Stanley	$172.00	$127.51	34.89%	90.29%
Sep 22, 2022		J.P. Morgan	$190.00	$126.16	50.60%	110.20%
Sep 02, 2022		Canaccord Genuity	$198.00	$149.29	32.63%	119.05%
Aug 05, 2022		BTIG	$178.00	$152.65	16.61%	96.92%
Jun 30, 2022	David Rescott	Truist Financial	$165.00	$108.03	52.74%	82.54%
Jun 29, 2022	Marie Thibault	BTIG	$155.00	$116.38	33.18%	71.48%
Jun 22, 2022		J.P. Morgan	$135.00	$111.26	21.34%	49.35%
May 06, 2022		Morgan Stanley	$190.00	$128.13	48.29%	110.20%
May 06, 2022		Needham	$179.00	$118.12	51.54%	98.03%

The latest iRhythm stock forecast, released on Oct 31, 2024 by Michael Matson from Needham, set a price target of $96.00, which represents a 26.70% increase from the stock price at the time of the forecast ($75.77), and a 6.21% increase from IRTC last price ($90.39).

iRhythm Price Target by Period

	1M	3M	12M
# Anlaysts	-	6	13
Avg Price Target	-	$97.67	$114.54
Last Closing Price	$90.39	$90.39	$90.39
Upside/Downside	-100.00%	8.05%	26.72%

In the current month, the average price target of iRhythm stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to iRhythm's last price of $90.39. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 31, 2024	Needham	Buy	Buy	Hold
Oct 22, 2024	Oppenheimer	Outperform	Outperform	Hold
Oct 22, 2024	BTIG	Buy	Buy	Hold
Oct 04, 2024	Goldman Sachs		Neutral	Initialise
Aug 02, 2024	Oppenheimer	Outperform	Outperform	Hold
Aug 02, 2024	BTIG	Buy	Buy	Hold
Jun 20, 2024	Wolfe Research		Outperform	Upgrade
May 29, 2024	BTIG	Buy	Buy	Hold
May 20, 2024	Wells Fargo	Overweight	Overweight	Hold
May 06, 2024	Citigroup	Buy	Buy	Hold
Jun 07, 2023	Citigroup	Neutral	Neutral	Hold
Feb 24, 2023	Needham	Buy	Buy	Hold
Feb 24, 2023	William Blair	Outperform	Outperform	Hold
Feb 07, 2023	BTIG	Buy	Neutral	Initialise
Feb 07, 2023	UBS		Buy	Initialise
Feb 07, 2023	Zelman		Hold	Initialise
Feb 07, 2023	Raymond James		Strong Buy	Initialise
Feb 07, 2023	JMP Securities		Market Outperform	Initialise
Feb 07, 2023	Chardan Capital		Buy	Initialise
Feb 07, 2023	Keefe, Bruyette & Woods		Outperform	Initialise
Feb 07, 2023	Piper Sandler		Overweight	Initialise
Feb 07, 2023	Stephens		Overweight	Initialise
Feb 07, 2023	Loop Capital Markets		Hold	Initialise
Feb 07, 2023	Wells Fargo		Overweight	Initialise
Jan 06, 2023	Morgan Stanley	Overweight	Overweight	Hold
Dec 12, 2022	Citigroup	Neutral	Neutral	Hold
Sep 22, 2022	Morgan Stanley	Overweight	Overweight	Hold
Sep 02, 2022	Canaccord Genuity	Buy	Buy	Hold
Aug 05, 2022	BTIG	Buy	Buy	Hold
Jun 24, 2022	BTIG	Buy	Buy	Hold
Feb 24, 2022	Morgan Stanley	Overweight	Overweight	Hold

iRhythm's last stock rating was published by Needham on Oct 31, 2024. The company gave IRTC a "Buy" rating, the same as its previous rate.

iRhythm Financial Forecast

iRhythm Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$124.60M	$124.13M	$111.44M	$112.62M	$103.88M	$102.05M	$92.38M	$81.80M	$85.43M	$81.28M	$74.31M	$78.81M	$71.94M	$50.88M	$63.53M	$59.10M	$54.67M
Avg Forecast	$215.15M	$201.01M	$201.89M	$181.58M	$182.93M	$171.73M	$172.46M	$154.21M	$157.12M	$147.00M	$146.15M	$128.41M	$130.20M	$122.61M	$120.29M	$107.05M	$110.26M	$105.86M	$100.36M	$86.76M	$78.30M	$83.89M	$72.71M	$70.27M	$76.59M	$62.34M	$42.18M	$61.40M	$58.42M	$53.75M
High Forecast	$217.83M	$203.52M	$204.41M	$183.85M	$185.22M	$173.88M	$174.61M	$155.83M	$157.95M	$147.06M	$146.15M	$128.41M	$133.56M	$123.64M	$121.80M	$108.38M	$111.63M	$105.86M	$100.36M	$86.76M	$78.30M	$83.89M	$72.71M	$70.27M	$76.59M	$62.34M	$42.18M	$61.40M	$58.42M	$53.75M
Low Forecast	$212.83M	$198.84M	$199.72M	$179.63M	$180.96M	$169.88M	$170.60M	$152.88M	$156.09M	$146.94M	$146.15M	$128.41M	$129.14M	$121.31M	$119.00M	$105.89M	$109.07M	$105.86M	$100.36M	$86.76M	$78.30M	$83.89M	$72.71M	$70.27M	$76.59M	$62.34M	$42.18M	$61.40M	$58.42M	$53.75M
# Analysts	3	3	3	3	4	4	4	6	8	4	4	4	5	10	9	9	8	8	8	8	9	9	9	9	9	15	9	9	16	8
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.02%	1.03%	1.04%	1.02%	0.98%	1.02%	1.06%	1.04%	1.02%	1.12%	1.06%	1.03%	1.15%	1.21%	1.03%	1.01%	1.02%

iRhythm's average Quarter revenue forecast for Dec 23 based on 5 analysts is $130.20M, with a low forecast of $129.14M, and a high forecast of $133.56M. IRTC's average Quarter revenue forecast represents a 4.49% increase compared to the company's last Quarter revenue of $124.60M (Sep 23).

iRhythm EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	3	3	4	4	4	6	8	4	4	4	5	10	9	9	8	8	8	8	9	9	9	9	9	15	9	9	16	8
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-27.60M	$-18.87M	$-33.13M	$-19.11M	$-20.72M	$-18.71M	$-12.24M	$-34.12M	$-19.00M	$-13.11M	$-23.75M	$-11.82M	$-975.00K	$-16.77M	$-5.62M	$-23.16M	$-14.51M
Avg Forecast	$-42.05M	$-39.28M	$-39.46M	$-35.49M	$-35.75M	$-33.56M	$-33.70M	$-30.14M	$-30.71M	$-28.73M	$-28.56M	$-59.19M	$-25.45M	$-23.96M	$-23.51M	$-53.80M	$-39.78M	$-23.46M	$-22.24M	$-48.91M	$-17.35M	$-18.59M	$-16.11M	$-20.32M	$-16.97M	$-13.82M	$-9.35M	$-7.20M	$-12.95M	$-11.91M
High Forecast	$-41.59M	$-38.86M	$-39.03M	$-35.11M	$-35.37M	$-33.20M	$-33.34M	$-29.88M	$-30.51M	$-28.72M	$-28.56M	$-47.35M	$-25.24M	$-23.71M	$-23.26M	$-43.04M	$-31.82M	$-23.46M	$-22.24M	$-39.13M	$-17.35M	$-18.59M	$-16.11M	$-16.26M	$-16.97M	$-13.82M	$-9.35M	$-5.76M	$-12.95M	$-11.91M
Low Forecast	$-42.57M	$-39.77M	$-39.95M	$-35.93M	$-36.20M	$-33.98M	$-34.13M	$-30.45M	$-30.87M	$-28.74M	$-28.56M	$-71.02M	$-26.10M	$-24.16M	$-23.80M	$-64.57M	$-47.73M	$-23.46M	$-22.24M	$-58.70M	$-17.35M	$-18.59M	$-16.11M	$-24.38M	$-16.97M	$-13.82M	$-9.35M	$-8.64M	$-12.95M	$-11.91M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.15%	0.80%	0.62%	0.48%	0.88%	0.84%	0.25%	1.97%	1.02%	0.81%	1.17%	0.70%	0.07%	1.79%	0.78%	1.79%	1.22%

undefined analysts predict IRTC's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than iRhythm's previous annual EBITDA (undefined) of $NaN.

iRhythm Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	3	3	4	4	4	6	8	4	4	4	5	10	9	9	8	8	8	8	9	9	9	9	9	15	9	9	16	8
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-27.12M	$-18.48M	$-39.11M	$-20.20M	$-21.45M	$-23.90M	$-50.61M	$-32.49M	$-23.73M	$-17.36M	$-27.78M	$-9.65M	$-4.68M	$-20.44M	$-9.06M	$-17.30M	$-18.29M
Avg Forecast	$-412.66K	$-4.76M	$-4.15M	$-16.88M	$-9.96M	$-14.71M	$-15.46M	$-21.57M	$-10.22M	$-24.84M	$-27.93M	$-77.11M	$-18.09M	$-19.90M	$-23.80M	$-70.10M	$-37.88M	$-25.44M	$-28.46M	$-63.73M	$-36.42M	$-31.86M	$-29.39M	$-23.76M	$-9.11M	$-15.99M	$-24.96M	$-11.62M	$-16.50M	$-12.25M
High Forecast	$-406.88K	$-4.69M	$-4.09M	$-16.64M	$-9.83M	$-14.50M	$-15.24M	$-17.76M	$-2.39M	$-24.49M	$-27.54M	$-61.69M	$-7.54M	$-16.58M	$-23.47M	$-56.08M	$-30.30M	$-25.44M	$-28.46M	$-50.98M	$-36.42M	$-31.86M	$-29.39M	$-19.01M	$-9.11M	$-15.99M	$-24.96M	$-9.29M	$-16.50M	$-12.25M
Low Forecast	$-419.35K	$-4.84M	$-4.22M	$-17.15M	$-10.13M	$-14.95M	$-15.71M	$-27.91M	$-15.67M	$-25.25M	$-28.38M	$-92.54M	$-24.42M	$-22.61M	$-24.19M	$-84.12M	$-45.45M	$-25.44M	$-28.46M	$-76.48M	$-36.42M	$-31.86M	$-29.39M	$-28.52M	$-9.11M	$-15.99M	$-24.96M	$-13.94M	$-16.50M	$-12.25M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.36%	0.78%	0.56%	0.53%	0.84%	0.84%	0.79%	0.89%	0.74%	0.59%	1.17%	1.06%	0.29%	0.82%	0.78%	1.05%	1.49%

iRhythm's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. IRTC's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

iRhythm SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	3	3	4	4	4	6	8	4	4	4	5	10	9	9	8	8	8	8	9	9	9	9	9	15	9	9	16	8
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$93.77M	$91.42M	$100.34M	$86.73M	$80.56M	$81.75M	$73.16M	$71.61M	$70.75M	$62.67M	$69.81M	$56.29M	$49.70M	$43.01M	$48.23M	$53.65M	$45.65M
Avg Forecast	$172.06M	$160.76M	$161.46M	$145.22M	$146.30M	$137.34M	$137.93M	$123.33M	$125.65M	$117.56M	$116.89M	$111.47M	$104.13M	$98.05M	$96.20M	$101.34M	$83.49M	$84.66M	$80.26M	$69.38M	$62.62M	$67.09M	$58.15M	$59.72M	$61.26M	$49.86M	$33.74M	$49.11M	$46.72M	$42.99M
High Forecast	$174.21M	$162.76M	$163.48M	$147.03M	$148.13M	$139.06M	$139.65M	$124.62M	$126.32M	$117.61M	$116.89M	$133.77M	$106.82M	$98.88M	$97.41M	$121.60M	$100.18M	$84.66M	$80.26M	$69.38M	$62.62M	$67.09M	$58.15M	$71.66M	$61.26M	$49.86M	$33.74M	$49.11M	$46.72M	$42.99M
Low Forecast	$170.21M	$159.02M	$159.72M	$143.66M	$144.72M	$135.86M	$136.44M	$122.26M	$124.84M	$117.51M	$116.89M	$89.18M	$103.28M	$97.01M	$95.17M	$81.07M	$66.79M	$84.66M	$80.26M	$69.38M	$62.62M	$67.09M	$58.15M	$47.78M	$61.26M	$49.86M	$33.74M	$49.11M	$46.72M	$42.99M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.96%	0.95%	0.99%	1.04%	0.95%	1.02%	1.05%	1.14%	1.05%	1.08%	1.17%	0.92%	1.00%	1.28%	0.98%	1.15%	1.06%

iRhythm's average Quarter SG&A projection for Dec 23 is $104.13M, based on 5 Wall Street analysts, with a range of $103.28M to $106.82M. The forecast indicates a 11.05% rise compared to IRTC last annual SG&A of $93.77M (Sep 23).

iRhythm EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	3	3	4	4	4	6	8	4	4	4	5	10	9	9	8	8	8	8	9	9	9	9	9	15	9	9	16	8
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.89	$-0.61	$-1.29	$-0.67	$-0.71	$-0.80	$-1.71	$-1.10	$-0.81	$-0.59	$-0.95	$-0.33	$-0.17	$-0.75	$-0.34	$-0.65	$-0.74
Avg Forecast	$-0.01	$-0.15	$-0.13	$-0.54	$-0.32	$-0.47	$-0.49	$-0.69	$-0.33	$-0.79	$-0.89	$-0.97	$-0.58	$-0.64	$-0.76	$-0.90	$-0.63	$-0.82	$-0.91	$-1.10	$-1.17	$-1.02	$-0.94	$-0.83	$-0.29	$-0.51	$-0.80	$-0.59	$-0.53	$-0.39
High Forecast	$-0.01	$-0.15	$-0.13	$-0.53	$-0.31	$-0.46	$-0.49	$-0.57	$-0.08	$-0.78	$-0.88	$-0.96	$-0.24	$-0.53	$-0.75	$-0.89	$-0.62	$-0.82	$-0.91	$-1.10	$-1.17	$-1.02	$-0.94	$-0.83	$-0.29	$-0.51	$-0.80	$-0.59	$-0.53	$-0.39
Low Forecast	$-0.01	$-0.15	$-0.13	$-0.55	$-0.32	$-0.48	$-0.50	$-0.89	$-0.50	$-0.81	$-0.91	$-0.99	$-0.78	$-0.72	$-0.77	$-0.91	$-0.64	$-0.82	$-0.91	$-1.10	$-1.17	$-1.02	$-0.94	$-0.83	$-0.29	$-0.51	$-0.80	$-0.59	$-0.53	$-0.39
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.40%	0.80%	1.44%	1.07%	0.87%	0.88%	1.56%	0.94%	0.79%	0.63%	1.14%	1.13%	0.33%	0.94%	0.57%	1.23%	1.88%

According to undefined Wall Street analysts, iRhythm's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to IRTC previous annual EPS of $NaN (undefined).

iRhythm Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
SGHT	Sight Sciences	$3.62	$7.50	107.18%	Hold
KIDS	OrthoPediatrics	$22.46	$39.50	75.87%	Buy
LIVN	LivaNova	$49.94	$68.25	36.66%	Buy
BRKR	Bruker	$57.81	$79.00	36.65%	Buy
CNMD	CONMED	$71.23	$97.00	36.18%	Buy
OFIX	Orthofix Medical	$17.93	$24.00	33.85%
NPCE	NeuroPace	$11.52	$15.00	30.21%	Buy
IRTC	iRhythm	$91.45	$111.38	21.79%	Buy
ITGR	Integer	$136.68	$153.50	12.31%	Buy
FNA	Paragon 28	$10.36	$11.50	11.00%	Buy
SRDX	Surmodics	$39.96	$39.50	-1.15%	Buy
GKOS	Glaukos	$146.35	$144.14	-1.51%	Buy

IRTC Forecast FAQ

Is iRhythm a good buy?

Yes, according to 19 Wall Street analysts, iRhythm (IRTC) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 15 'Buy' recommendations, accounting for 84.21% of IRTC's total ratings.

What is IRTC's price target?

iRhythm (IRTC) average price target is $111.38 with a range of $78 to $145, implying a 23.22% from its last price of $90.39. The data is based on 19 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will iRhythm stock go up soon?

According to Wall Street analysts' prediction for IRTC stock, the company can go up by 23.22% (from the last price of $90.39 to the average price target of $111.38), up by 60.42% based on the highest stock price target, and down by -13.71% based on the lowest stock price target.

Can iRhythm stock reach $140?

IRTC's highest twelve months analyst stock price target of $145 supports the claim that iRhythm can reach $140 in the near future.

What are iRhythm's analysts' financial forecasts?

iRhythm's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $681.33M (high $689.53M, low $674.32M), average EBITDA is $-133M (high $-132M, low $-135M), average net income is $-61.697M (high $-57.329M, low $-68.691M), average SG&A $544.9M (high $551.45M, low $539.29M), and average EPS is $-1.974 (high $-1.834, low $-2.197). IRTC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $799.63M (high $809.61M, low $791.01M), average EBITDA is $-156M (high $-155M, low $-158M), average net income is $-26.199M (high $-25.832M, low $-26.624M), average SG&A $639.5M (high $647.48M, low $632.61M), and average EPS is $-0.838 (high $-0.826, low $-0.852).

Did the IRTC's actual financial results beat the analysts' financial forecasts?

Based on iRhythm's last annual report (Dec 2022), the company's revenue was $410.92M, beating the average analysts forecast of $403.23M by 1.91%. Apple's EBITDA was $-85.14M, missing the average prediction of $-134M by -36.65%. The company's net income was $-116M, missing the average estimation of $-155M by -25.30%. Apple's SG&A was $322.2M, beating the average forecast of $317.79M by 1.39%. Lastly, the company's EPS was $-3.88, beating the average prediction of $-3.453 by 12.35%. In terms of the last quarterly report (Sep 2023), iRhythm's revenue was $124.6M, beating the average analysts' forecast of $122.61M by 1.63%. The company's EBITDA was $-27.603M, beating the average prediction of $-23.961M by 15.20%. iRhythm's net income was $-27.116M, beating the average estimation of $-19.897M by 36.28%. The company's SG&A was $93.77M, missing the average forecast of $98.05M by -4.37%. Lastly, the company's EPS was $-0.89, beating the average prediction of $-0.636 by 39.84%